JHLT: The Podcast

JHLT: The Podcast starts May with an important ten-year update to a keystone document—the "ISHLT Consensus Conference on Graft Dysfunction within the First 72 Hours after Heart Transplantation." The consensus summary—and a perspective piece by the authors—appears in the May issue of JHLT, and is available in full on ISHLT.org.
The podcast is happy to host conference leader and first author Jon Kobashigawa, MD, Cedars-Sinai in Los Angeles, to talk about the consensus document, the conference, and PGD.
The conversation includes discussion of:
Why the document needed updating and how consensus was achieved
The revised severity scale for PGD and the omission of the vasoactive-inotropic score
Changes from the old document, including: Newer predictors of PGD
The latest donor preservation devices
Updated treatment approaches

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.
Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

In this episode, JHLT: The Podcast highlights a special issue of the Journal of Heart and Lung Transplantation that's just been released. The issue focuses on innovations in Device Therapies, and was edited by JHLT Deputy Editor Manreet Kanwar, MD, FACC, of the University of Chicago. Dr. Kanwar joins Digital Media Editor Van-Khue Ton, MD, PhD for a discussion about the special issue.
The discussion explores:
The importance of discussing device therapies in the advanced heart and lung failure communities
The most anticipated device therapies in the pipeline for clinicians and patients to consider
The impact of publishing in JHLT
For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Read the special issue on ScienceDirect or at the Journal website.
Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

JHLT: The Podcast kicks off April with a discussion of the paper, "Lung Cancer After Lung Transplantation: Early Detection and Curative Surgery Drive Long-Term Survival," which appears in the April issue of JHLT.
Senior author Pauline Pradère, MD, of Hôpital Marie Lannelongue in Paris, joins the episode to talk about the paper.
The conversation includes discussion of:
The overall survival of patients who develop lung cancer after lung transplant—and the key differences between the cohort of patients who developed cancer versus the patients who did not
Managing lung cancer in transplant recipients
Immunosuppression in these patients, and other potential changes to clinical practice derived from the study
For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.
Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

JHLT: The Podcast continues a themed month on HIV infection in solid organ transplant, building on our last episode's exploration from Dr. Saeed at Montefiore in New York.
Our guest this episode is infectious diseases expert Cameron Wolfe, MD, Professor of Medicine at Duke University Medical Center. He joined us while on sabbatical with his family in Brisbane Australia for a conversation about how transplant centers now consider HIV infection, including transplant recipients who are HIV positive.
The discussion explores:
How the HOPE Act of 2013 changed practice in the United States, and how other countries have handled HIV transplantation regulations
Immunosuppresion, antiviral therapy, and opportunistic infection in HIV+ transplant recipients
Whether organ-specific surveillance changes in HIV+ patients
The ethics of using organs from HIV+ donors and ensuring HIV+ patients are treated equitably
For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

This month on JHLT: The Podcast, the Digital Media Editors host two themed discussions around HIV in solid organ transplantation. The conversation begins with a discussion of the paper, "Early experience in heart transplantation utilizing donors with HIV," which appears in the March issue of JHLT.
First author Omar Saeed, MD, MSc, of the Division of Cardiology at Montefiore Medical Center in New York, NY USA, joins the episode.
The conversation includes discussion of:
The ethics and evolution of the Montefiore program's transplant eligibility and criteria
The role of the HOPE Act in the changes to the program
Superinfection, viral strain analysis, and informed consent of organ recipients
Long-term patient follow upsa nd how other centers can begin this research
For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.
Return later this month for a broader conversation with an infectious diseases expert about HIV in transplantation.
Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.